Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Janux Therapeutics Inc (JANX) has issued an update.
The Company has released interim clinical data to the public via a press release and a detailed corporate presentation, which investors can find on the Company’s website under the “Investors” section. This information, while important, is not intended for official filing purposes and should not be considered filed under U.S. securities law, nor will it be incorporated by reference into future SEC filings.
For detailed information about JANX stock, go to TipRanks’ Stock Analysis page.